Panacea Biotec Ltd

531349

Overview

    • Equity Style Box

      Small Blend

    • Sector

      Healthcare

    • Industry

      Biotechnology

    • Day Range

      409.00 – 422.95

    • Year Range

      129.65 – 581.00

    • Market Cap

      25.1924 Bil

    • Volume / Avg

      4.9 k / 29.7 k

    • Price / Sales

      4.49

    • Price / Book

      3.02

    • Price / Earnings

      —

    • Forward Div Yield

      0.00%

    • Trailing Div Yield

      —

Login To Show Full Chart

Summary

Fair Value Assessment
Overvalued (13% Premium)
Fair ValueQ362.63UncertaintyHigh
Close Price411.30Jul 04, 2025
Market Closed
₹ 411.30
Price Down by 6.55 | 1.57 %
Trading Information Business Description
Previous Close
411.30
Day Range
409.00 – 422.95
Year Range
129.65 – 581.00
Bid / Ask
—
Market Cap
25.2 Bil
Volume / Average
4.9 k / 29.7 k
Beta (5-Year)
–
Shares Outstanding
61.25 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.
Contact
Mathura Road, B-1 Extension/G-3 Mohan Co-operative Industrial Estate, New Delhi 110 044
T +91 1141679000
www.panaceabiotec.com opens in a new tab
Sector
Healthcare
Industry
Biotechnology
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
1,302
As of Mar 31, 2024

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
5.59 5.59 5.52 4.57 6.59 6.18
Revenue Growth %
-0.01% -0.01% 20.79% -30.69% 6.73% 14.98%
Gross Profit
3.60 3.60 2.83 1.78 3.42 3.89
Gross Profit Margin %
64.31% 64.31% 51.27% 38.99% 51.81% 63.00%
Operating Income
-0.61 -0.61 -0.44 -1.06 -0.53 0.37
Operating Margin %
-10.86% -10.86% -8.01% -23.12% -8.06% 5.95%
EBIT
-0.04 -0.04 -0.04 0.05 16.25 0.37
EBIT Margin %
-0.73% -0.73% -0.77% 1.10% 246.54% 6.02%
EBITDA
0.31 0.31 0.32 0.44 16.69 0.83
EBITDA Margin %
5.50% 5.50% 5.89% 9.67% 253.16% 13.48%
Net Income
-0.08 -0.08 -0.01 -0.33 10.78 -1.48
Net Profit Margin %
-1.56% -1.56% -0.27% -7.39% 163.51% -23.67%
Basic EPS
-1.37 -1.37 -0.19 -5.43 175.98 -24.11
Diluted EPS
-1.37 -1.37 -0.19 -5.43 175.98 -24.11
Normalized EPS
— — — — — —
Total Dividends per Share
— — — — — —
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
12.90 12.90 12.41 12.71 17.83 11.79
Total Liabilities
4.59 4.59 4.02 4.31 9.37 14.11
Total Debt
0.22 0.22 0.15 0.20 0.34 8.20
Total Equity
8.31 8.31 8.38 8.40 8.46 -2.32
Cash And Cash Equivalents
0.82 0.82 0.47 0.40 0.50 0.52
Working Capital
1.78 1.78 1.76 2.36 2.38 0.85
Shares Outstanding (Mil)
— — 61.25 61.25 61.25 61.25
Book Value Per Share
136.29 136.29 137.48 137.73 138.58 -37.34
Total Debt To Equity
0.03 0.03 0.02 0.02 0.04 —
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Bil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
-0.27 — -4.22 -1.08 1.07 -0.30
Cash From Investing Activities
0.65 0.10 4.30 12.83 -0.48 -0.35
Cash From Financing Activities
-0.03 -0.03 -0.18 -11.76 -0.47 0.91
Capital Expenditures
0.50 0.78 0.41 0.13 0.22 0.07
Free Cash Flow
-0.72 -0.90 -1.30 -8.12 -0.36 0.15
Change in Cash
0.35 0.07 -0.10 -0.02 0.12 0.26

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

Ownership lists the Fund owners and Intitutional owners of the stock.
Name
Morningstar
Rating
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Current Shares
Change Amount
Change %
Date
Dimensional Emerging Core Equity Mkt ETF 0.03 0.00 18,864
0
0.00%
Jun 30, 2025
DFA Emerging Markets Core Equity 2 I 0.02 0.00 10,283
0
0.00%
May 31, 2025
Dimensional Emerging Markets Cr Eq 2 ETF 0.01 0.00 8,830
0
0.00%
Jun 30, 2025
Dimensional EM Core Equity Acc 0.01 0.00 4,862
0
0.00%
May 31, 2025
Dimensional Emerg Mkt Trgtd Val USD Acc 0.01 0.00 4,002
0
0.00%
May 31, 2025
Total (for Top 5) 0.08 46,841
0
More Ownership Data

STOCKS
MUTUAL FUNDS
ADITYABIRLAAXISBajajBANDHANBARODABNPBOICANARADSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top